The different names for tirzepatide and what they actually mean

The myth: different names mean different medicines, or a cheaper version

A lot of people arrive at our prescribers having Googled "tirzepatide" after seeing "Mounjaro" quoted at a price they weren't expecting. The assumption is natural: if there's a generic name, there must be a generic product, probably cheaper. That's how it works with paracetamol or ibuprofen. With tirzepatide it doesn't, and understanding why protects you from a genuine safety risk.

Tirzepatide is a large, complex biological molecule, a dual GIP and GLP-1 receptor agonist. It takes Eli Lilly's proprietary manufacturing process to produce it to the standard required for human use. No biosimilar version exists in the UK, and none holds MHRA authorisation. When sellers advertise "generic tirzepatide" or "tirzepatide pens" at a fraction of Mounjaro's price, they are either importing product from an unregulated supply chain or, in the worst cases documented by the MHRA, selling counterfeit pens. The MHRA has seized roughly 20 million doses of illegally traded weight-loss medicines (worth around £45 million) and in October 2025 raided the UK's first illicit manufacturing site producing counterfeit tirzepatide pens. The name on the box is your first line of defence: in the UK, it should say Mounjaro. You can read the MHRA's public guidance on reporting suspect sellers via the Yellow Card scheme.

The short version: same molecule, one legitimate UK product, one legitimate UK name.

Mounjaro, Zepbound, and why the US name keeps appearing in UK searches

Eli Lilly chose different brand names for different regulatory territories. In the UK and across most of Europe, tirzepatide for weight management is sold as Mounjaro. In the United States, the weight-loss version was approved under the name Zepbound. The same company, the same molecule, two different marketing authorisations in two different regulatory systems.

Zepbound generates a lot of search traffic in the UK because American health media and social platforms reach British readers. That's not a problem in itself, but it creates confusion when people assume they can order Zepbound from a UK pharmacy, or that Zepbound pricing translates to what they'll pay here. It doesn't. Zepbound does not exist as a UK product; no UK pharmacy can legally dispense it, and any seller claiming to supply it is not operating within the licensed UK supply chain. If you've been researching tirzepatide brand names and hit a wall of American content, that's why.

For UK readers, the practical answer is simple: Mounjaro is what's licensed here, and Mounjaro is what a legitimate UK prescriber will prescribe.

Other names you may encounter: trade names, the INN, and the science

Beyond Mounjaro and Zepbound, tirzepatide has appeared under a handful of other descriptors worth knowing. The International Non-proprietary Name (INN) (the name agreed by the World Health Organization for the active substance) is simply "tirzepatide". This is the name used in clinical trial papers, the British National Formulary, and NICE guidance. When the NICE technology appraisal TA1026 recommends tirzepatide for adults with a BMI of 35 or above alongside a weight-related health condition, it uses the INN, not the brand name, that's standard practice in clinical guidance.

You may also come across "LY3298176", Eli Lilly's internal compound code used in early-phase research. It predates the INN and appears in some academic papers from before the name tirzepatide was confirmed. It refers to exactly the same molecule. Similarly, some trade name discussions in the UK mention Mounjaro KwikPen, which simply describes the pen device format rather than a separate product, each Mounjaro KwikPen delivers four weekly doses from a single pre-filled device.

Eli Lilly also markets tirzepatide under the brand name Mounjaro for type 2 diabetes management in the UK, which uses the same physical product. The licence and clinical use differ; the pen sitting in the fridge door is the same. That's another reason the INN matters: it spans both indications cleanly, while the brand name applies across them.

For context on how UK private treatment is priced, the cost of Mounjaro in the UK page sets out what drives price variation between providers and what a transparent, all-inclusive price should cover. Worth reading before comparing quotes. If you want a broad overview of what's licensed for weight management right now, the weight-loss treatments overview covers the full picture.

What name to give your pharmacist or prescriber

When you speak to any UK clinician or pharmacist, "Mounjaro" or "tirzepatide" both work, they are interchangeable in a clinical conversation. If you've transferred from another provider and want to continue treatment, your prescription will name the medicine as either Mounjaro or tirzepatide depending on the prescriber's software; both are valid for dispensing.

A GPhC-registered pharmacy will dispense Mounjaro sourced through the authorised UK supply chain. Eli Lilly supplies the UK market through authorised wholesalers; at nume, medicines are sourced exclusively through that licensed channel. If a name other than Mounjaro appears on packaging supplied to you as a UK weight-management prescription, that is a red flag worth investigating before you use the product. You can verify any online pharmacy on the GPhC's public register before handing over any personal or medical information.

Understanding why tirzepatide has different names in different contexts is genuinely useful, but it shouldn't distract from the central point: in the UK, one product is licensed, one regulatory body oversees it, and one register lists the pharmacies authorised to dispense it. If you'd like to find out whether Mounjaro is clinically suitable for you, our prescribers are available for a free consultation, reviewed by a qualified Independent Prescriber the same day.